COMMUNIQUÉS West-GlobeNewswire

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
07/07/2026
CA-enabled PCPs showed better HEDIS® post-acute performance, including 33% higher discharge information receipt and an 11% higher rate of post-discharge medication reconciliation, underscoring the role of AI-enabled [...]
Amplia Announces Appointment of Brett Carter to Board
07/07/2026
Melbourne, Australia, July 07, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX, OTCQB:INNMF), (“Amplia” or the “Company”), is pleased to announce the appointment of Mr Brett Carter to the Board of [...]
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling
07/07/2026
Company also advances U.S. regulatory pathway for ONP-002 with FDA Type B meeting request All three Australian Phase IIa trial sites — Mackay Base Hospital, Alfred Health, and Royal Adelaide Hospital — are now active [...]
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation
07/07/2026
Realbotix Robots and AI to Deploy in Evidence-Based Pilot Designed to Improve Wellbeing and Address Loneliness Among Older Adults in UK Care Settings; Realbotix Becomes Accredited Supplier on Bloom’s Public Sector [...]
New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
07/07/2026
New SCCT abstracts from Brigham and Women’s Hospital highlight the performance and clinical utility of Nanox.AI’s FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its potential role in [...]
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
07/07/2026
Conexeu Completes 12-Month Preclinical P.R.O.O.F Study, Supporting Its Intended Move Into the $11 Billion Medical Aesthetics Market as a Platform¹ Study Highlights P.R.O.O.F study complete, marking an important catalyst [...]
Cynet Joins Pax8 Marketplace to Help MSPs Manage the Modern Attack Path
07/07/2026
Availability on Pax8 makes it easy for MSPs to purchase Cynet alongside the technology they use to run their business BOSTON, July 07, 2026 (GLOBE NEWSWIRE) -- Cynet , the leader in attack path management, announced the [...]
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
07/07/2026
ARLINGTON, Va., July 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2026 [...]
European Medicines Agency Expedites Assessment of Revolution Medicines’ Daraxonrasib Under Phased Review Process
07/07/2026
Phased review by EMA aims to accelerate assessment of company's investigational drug daraxonrasib in pancreatic cancer based on unprecedented clinical results from pivotal Phase 3 RASolute 302 trial Rolling submission [...]
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
07/07/2026
Sets out Shared Intent to Support Delivery of Propanc’s First-In-Human Clinical Trial for PRP MELBOURNE, Australia, July 07, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), [...]
World First: KFSH Jeddah's Single-Session Stem Cell Protocol Sets a New Global Standard Balancing Donor Safety and Treatment Efficiency
07/07/2026
JEDDAH, Kingdom of Saudi Arabia, July 07, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre in Jeddah has successfully developed and implemented the world’s first protocol of its kind, using [...]
MAPS Publishes Ibogaine Investigator's Brochure as a Free, Open-Access Resource
07/07/2026
MAPS published a complete ibogaine Investigator’s Brochure (IB) — a research and regulatory document typically held as a proprietary industry asset — as a free, open-access resource. The IB compiles the known [...]
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
07/07/2026
Former White House Council of Economic Advisors Brings Extensive Government, Academic, and Private Sector Experience to Advance Company's Strategic Growth JUPITER, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Jupiter [...]
Stipple Bio Appoints Biopharma Business Development Leader Roland Gendron as Chief Business Officer
07/07/2026
– Seasoned executive brings extensive leadership experience spanning corporate development, business development and pipeline strategy – – Track record includes helping build and advance leading oncology franchises at [...]
Press Release Biocartis NV: Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics
07/07/2026
PRESS RELEASE, July 07, 2026 – 08:00 CDT Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics ITASCA, IL, US and HUNTSVILLE, AL, US – July 07, 2026. Today, [...]
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
07/07/2026
MIAMI, July 07, 2026 (GLOBE NEWSWIRE) -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical [...]
InStride Health’s New Peer-Reviewed Research Demonstrates Reductions in Caregiver Strain following Specialty Virtual Care for Families of Youth with Anxiety and OCD
07/07/2026
Research published in Discover Public Health shows that caregiver strain was lowered following evidence-based treatment regardless of patient complexity BOSTON, July 07, 2026 (GLOBE NEWSWIRE) -- InStride Health , a [...]
Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026
07/07/2026
Nu-Tek présentera des données démontrant comment ses nutriments pour milieux de culture sans composants d’origine animale améliorent le rendement, optimisent les procédés et renforcent la sécurité d’approvisionnement [...]
Carbonium Core CEO Details Strategy to Supply Critical Material Powering the AI-Driven Nuclear Renaissance
07/07/2026
Management outlines commercialization roadmap toward a potential $1.5 billion annual revenue opportunity as the Company seeks to build America's first commercial-scale domestic supply chain for nuclear-grade graphite [...]

Pages